연구 및 보고서
2026년 9월 4일•1분 읽기
Daewoong Pharmaceutical Secures Liver Organoid Technology via KRIBB Partnership
Daewoong Pharmaceutical signed a technology transfer agreement with the Korea Research Institute of Bioscience and Biotechnology to acquire liver organoid production and drug evaluation technology, aiming to improve nonclinical toxicity assessment and reduce R&D costs.
연구 및 보고서
2026년 8월 30일•1분 읽기
LIGACEM BioScience Unveils LCB 2.0 R&D Strategy Targeting ADC Innovation and Next‑Gen Modalities
LIGACEM BioScience announced its LCB 2.0 R&D roadmap at Global R&D Day 2026, aiming to boost ADC innovation, expand into next‑generation modalities and accelerate high‑value technology transfer.